Parkinson’s research boosted with BioFocus/Michael J Fox Foundation collaboration

BioFocus has signed a collaboration agreement with The Michael J Fox Foundation for Parkinson’s Research, a not-for-profit organisation focused on developing therapies for Parkinson’s disease. Under the agreement, BioFocus will perform fragment-based screening, assay development and hit-finding programs to identify compounds that have the basis for a novel Parkinson’s disease diagnostic test.

As the world’s largest private funder of Parkinson’s research, The Michael J Fox Foundation is dedicated to accelerating a cure for Parkinson’s disease and improved therapies for those living with the condition today. The foundation pursues its goals through a targeted research program coupled with active global engagement of scientists, Parkinson’s patients, business leaders, clinical trial participants, donors and volunteers.

In addition to funding over $240 million in research to date, the foundation has fundamentally altered the trajectory of progress towards a cure. Operating at the hub of worldwide Parkinson’s research, the foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases Parkinson’s awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world.